Ravamed OÜ is a OÜ based in Tartu linn, registry code 11378032, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €1 573 with 1 employees.
Turnover
1 573 €
↓ 86.5%vs Q2 2026
State taxes
68 €
↓ 97.3%vs Q2 2026
Labour taxes
0 €
Employees
1
±0vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry Scientific research and development · EMTAK 72
Turnover · Q3 20261 573 €
above 16% of companies
industry median 14 442 € · companies in the industry: 318
Labour taxes per employee0 €
above 2% of companies
industry median 2 218 € · companies in the industry: 234
Revenue · 202531 131 €
above 82% of companies
industry median 0 € · companies in the industry: 1 073
Net profit margin · 202594.5 %
above 93% of companies
industry median 13.5 % · companies in the industry: 597
Taxes and turnover
Q4 2023 – Q3 2026
Turnover, € Q3 2026: 1 573 € · −86.5% vs Q2 2026 · industry median 14 442 € · above 16% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Labour taxes per employee, € Q3 2026: 0 € · industry median 2 218 € · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
EmployeesQ3 2026: 1 · +0.0% vs Q2 2026State taxes, € Q3 2026: 68 € · −97.3% vs Q2 2026
Figures by quarter
Quarter
Turnover, €
State taxes, €
Labour taxes, €
Employees
Q3 2026
1 573
68
—
1
Q2 2026
11 681
2 552
—
1
Q1 2026
13 568
3 238
—
1
Q4 2025
10 579
2 529
—
1
Q3 2025
—
20
12
1
Q2 2025
20 553
4 451
—
—
Q1 2025
—
—
—
1
Q4 2024
243
87
—
1
Q3 2024
1 200
254
—
1
Q2 2024
67
—
—
1
Q1 2024
—
—
—
1
Q4 2023
—
—
—
1
Q3 2023
399
—
—
—
Q2 2023
32
—
—
1
Q1 2023
—
—
—
—
Q4 2022
—
—
—
—
Q3 2022
393
—
—
—
Q2 2022
1 582
—
—
—
Q1 2022
—
—
—
—
Labour taxes per employee per month
0 €
Turnover per employee in the quarter
1 573 €
Q3 2026 · calculated from EMTA data
Financials by year
2016 – 2025
Revenue, € 2025: 31 131 € · +2 057.4% vs 2024 · industry median 0 € · above 82% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit, € 2025: 29 422 € · +4 454.5% vs 2024 · industry median 0 € · above 90% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit margin, % 2025: 94.5 % · +49.7 pp vs the year before · industry median 13.5 % · above 93% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Assets, € 2025: 32 010 € · +1 046.5% vs 2024Equity, € 2025: 31 973 € · +1 153.4% vs 2024Employees2025: 0 · industry median 1 · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Financials by year
Year
Revenue, €
Net profit, €
Labour costs, €
Assets, €
Equity, €
Employees
2025
31 131
29 422
0
32 010
31 973
0
2024
1 443
646
0
2 792
2 551
0
2023
399
-721
0
2 019
2 019
0
2022
1 594
-1 781
0
2 740
2 740
0
2021
0
-24 400
0
4 521
4 521
0
2020
5 265
-21 659
268
28 921
28 921
0
2019
582
-25 411
0
50 785
50 580
0
2018
—
—
—
—
—
1
2017
—
—
—
—
—
1
2016
—
—
—
—
—
0
2015
—
—
—
—
—
0
2014
—
—
—
—
—
0
2013
—
—
—
—
—
0
2012
—
—
—
—
—
0
2011
—
—
—
—
—
0
2010
—
—
—
—
—
0
2009
—
—
—
—
—
0
2008
—
—
—
—
—
0
2007
—
—
—
—
—
0
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.